University

Alfonso Baldi graduated with honors in Medicine and Surgery in 1992. In 1996, he specialized in Pathological Anatomy. From 2001 to 2024, Dr. Baldi served as University Researcher and later as Associate Professor in Pathologic Anatomy at the University of Campania “L. Vanvitelli.”  Prof. Alfonso Baldi is currently Associate Professor in Pathological Anatomy at the Department of Life Sciences, Health and Health Professions, “Link Campus University” in Rome. Finally, Prof. Baldi is eligible for the National Scientific Qualification for Full Professor in Pathologic Anatomy MED/08 (2018 Call for Applications).

Prof Baldi's scientific production consists of 374 scientific publications surveyed on PubMed; number of citations 21160, H-factor 77 (source Google Scholar, updated July 2024). In addition, he edited as Editor for the Publishing House “NOVA SCIENCE” (NY, USA) two scientific texts entitled “Mesothelioma: from the bench side to the clinic,” ISBN 978-1-60021-789-0 and “Electroporation in Laboratory and Clinical Investigations” ISBN 978-1-61668-327-6. Finally, he served as Editor for Springer publishing house a scientific text entitled: “Skin Cancer; a practical approach.” ISBN 978-1-4614-7356-5 (number of chapter downloads at the end of 2023 equals 187,000).

ownership of several research funds.

Prof. Baldi received several institutional research assignments: Founding Member and Scientific Head of the FUTURA-onlus Association, which involves international tasks related to biomedical research; Scientific Head of the Italian Endometriosis Foundation, which involves international tasks related to translational research on endometriosis pathology; Member of the Scientific Committee of the Italian League Against Tumors (LILT), Provincial Section of Rome; Scientific Coordinator of the Melanoma Diagnosis and Treatment Center of the Italian League Fight Against Tumors (LILT), Metropolitan Association of Rome; Research Associate at the Institute of Biosciences and Bioresources of the CNR; Director of the Laboratory of Translational Pathology at CEINGE in Naples, Italy (until October 2018); Adjunct Professor at Temple University in Philadelphia, PA, USA (until June 2016) .

Prof. Baldi is Co-Founder and Chief Scientific Officer of Biopulse s.r.l., a company dedicated to the development and production of electromedical devices.

During periods of research activities abroad at Temple University and Thomas Jefferson University in Philadelphia, Prof Baldi made essential contributions to the identification of the Rb2/p130 oncosuppressor gene, its chromosomal localization in humans, the characterization of its genomic structure and the cloning of the murine homologous gene; and produced the first original observations on the role of cell cycle regulatory proteins in tumor progression. 

During his time as a contract researcher at the Rome Biomedical Campus and the Rome Cancer Institute, he characterized some of the molecular “pathways” responsible for melanoma neoplastic progression by focusing on the serine protease HtrA1. Finally, he generated original data regarding the role of apoptosis in post-infarct ventricular remodeling.

During his time at “L. Vanvitelli” University, he conducted a series of works on domestic laboratory animals to characterize the effects of electrochemotherapy treatment. This scientific activity led to the establishment of an industrial spin-off of which Prof. Baldi is scientific director. The company produces an electroporator (Onkodisruptor®) that is considered state-of-the-art in veterinary electrochemotherapy and has defined new electroporators for DNA vaccine and nanovesicle loading methods. 

Finally, in collaboration with the Italian Endometriosis Foundation for which he is Scientific Officer, Prof. Baldi has produced data fundamental to the understanding of the pathogenesis of endometriosis and its early diagnosis, including generating original in vitro and in vivo models.

Curriculum Vitae